Haw Par Corporation Limited (HAWPF)
Haw Par Corporation Limited operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Singapore, NW, SG. The stock last traded at $12.58, up 0.00% on the session, giving a market capitalisation of $2.78B. On trailing twelve-month figures it carries a trailing P/E of 13.21, a net margin of 115.4%. Its beta of 0.16 implies it has historically moved less than the broad market.
Haw Par Corporation Limited, a company established in 1969 and headquartered in Singapore, conducts a broad range of operations including the manufacturing, marketing, and distribution of healthcare products across Singapore, ASEAN countries, other parts of Asia, and international markets. Its business activities are structured into three main segments: 1. Healthcare: This division primarily focuses on the creation and worldwide distribution of topical analgesic solutions, notably recognized for its popular Tiger Balm and Kwan Loong brands. 2. Investments: This segment is engaged in capital market activities, specifically investing in publicly traded securities. Additionally, it possesses and leases out a significant portfolio of investment properties, which includes 45,324 square meters of commercial and industrial space located in Singapore and Malaysia. 3. Others: This segment delivers leisure and entertainment experiences, prominently featuring oceanariums designed for families and tourists. Beyond these core segments, Haw Par Corporation Limited also offers property leasing services for land, buildings, and office facilities, along with providing management support services.
Haw Par Corporation Limited is most often compared with the following Healthcare names: